Knowledge guide

LG 19: Kidney transplantation

Clinical Sciences

Advanced Trainees will describe the principles of the foundational sciences.

View

Eligibility and considerations

Advanced Trainees will assess the patient’s current condition and plan the next steps.

View

Undertaking Therapy

Advanced Trainees will monitor the progress of patients during the therapy.

View

Post Therapy

Advanced Trainees will know how to monitor and manage patients post-therapy.

View

Important specific issues

In addition to what is listed above, Advanced Trainees will identify important specific issues and the impact of these on diagnosis and management.

View
Transplant immunology
  • Management of highly sensitised recipients, including blood group incompatibility and paired exchange
  • The immunological basis for allograft rejection
  • The pharmacology of immunosuppressives used in transplantation, including their short- and long-term side effects and drug interactions
  • The process of tissue typing and crossmatching, and how to interpret tissue typing reports
  • The risk factors for HLA sensitisation, which can include the role of epitope matching for recipients expected to need future transplantation
  • Recipient eligibility
  • Blood group, human leukocyte antigen (HLA) testing, and sensitisation and impacts on graft waiting times and outcomes
  • Cancer (previous cancer and screening)
  • Cardiac investigations
  • Cause of kidney disease
  • Comorbidities
  • Counselling patients, family and/or carers regarding benefit and risk of transplant and the process of eligibility, activation, donor offers, and acute and chronic transplant management
  • Inclusion and exclusion criteria:
    • absolute and relative
    • cardiovascular status and function
    • cognitive and carer factors
    • metabolic
    • socioeconomic factors
  • Infection in particular viral status and prophylaxis including:
    • cytomegalovirus (CMV)
    • Epstein–Barr virus (EBV)
    • hepatitis B and C
    • HIV
  • Medical and psychological complications of transplant
  • Urinary tract and bladder function
  • Vaccinations
  • Vascular imaging
  • Kidney donors
    • Living donor (e.g. related versus unrelated, directed, paired kidney exchange and chains, altruistic):
      • donor evaluation
      • ethics of donation
      • outcomes and short- and long-term donor risks
      • paired kidney donation and chains
      • post-transplant follow-up of transplant donor
      • potential donor counselling and/or referral to specialist services, e.g. psychiatric, cardiac, and anaesthetic assessment
      • understand organisations including Donate Life as a strategy for improving organ availability
    • Deceased donor kidney transplantation:
      • deceased donor wait list process
      • donor risk – high kidney donor profile index (KDPI), increased viral risk, cancer risk
      • how the allocation system works, which strongly informs whether or not to accept a kidney offer
      • kidney transplant outcomes
      • types (e.g. DBD, DCD, SCD, ECD)
  • Reviewing a kidney donation
    • Current data recorded by ANZDATA living kidney donor registry
    • Incompatible live donors
    • Protocols of the local transplant unit
    • Reviewing and accepting a donor organ offered to a patient
  • Acute transplant, including:
    • immunosuppression, particularly risks and benefits of commonly used drugs (calcineurin inhibitors (CNI), glucocorticoids, mammalian target of rapamycin (mTOR) inhibitors, antimetabolites and monoclonal antibodies):
      • effects
      • induction
      • maintenance
    • perioperative management
    • preparation of a patient
  • Comorbidities in patients due to conditions including cardiovascular disease, hypertension, and obstruction
Short-term
  • Bone status evaluation and treatment
  • Complications and their short- and long-term impacts, including:
    • BK virus nephropathy
    • diabetes, including worsening of pre-existing diabetes or new onset diabetes after transplant (NODAT)
    • diarrhoea
    • neutropenia
  • Evaluation of graft function and dysfunction in the early post-transplant period
  • Fluid management
  • Immunosuppression
  • Kidney transplant biopsy indications and interpretation, including use of Banff classification in the diagnosis of acute rejection
  • Management of cytomegalovirus (CMV) viraemia and infection
  • Management of early complications
  • Management of rejection:
    • antibody mediated
    • hyperacute
    • T-Cell mediated
  • Management of the failing graft
  • Radiological investigation, such as ultrasound scan and radioisotope scanning
  • Prophylactic antibiotics
  • Transplant glomerulopathy
Long-term
  • Bone health
  • Living with a donor kidney:
    • counselling regarding healthy lifestyle
    • immunosuppression
    • prescribe and monitor effects
    • regular outpatient review
  • Prevent, identify, and manage longer-term complications:
    • increased risk of cardiovascular disease
    • increased risk of malignant disease, including post-transplant lymphoproliferative disease (PTLD) and other cancers
    • primary kidney disease recurrence
  • Strategies that maximise long-term graft function and survival
  • BK virus diagnosis and management
  • Combined kidney and pancreatic transplant
  • Ethical issues in organ transplantation
  • Interpretation of kidney biopsy histopathology changes, including:
    • BK nephropathy » calcineurin inhibitor toxicity
    • rejection » thrombotic microangiopathy (TMA)
    • transplant glomerulopathy
  • Male and female fertility in transplantation
  • Organ sharing and allocation processes
  • Other organ transplant including liver, lung, and heart
  • Patients with known comorbid conditions which make transplant difficult, including:
    • diabetes
    • obesity
    • polycystic kidney disease
    • vascular disease
  • Pregnancy in patients with transplanted kidneys:
    • evaluating and minimising risks to kidney transplant
    • evaluating and minimising risks to mother
    • fetal outcomes
  • Previous transplant patients being retransplanted: » graft removal prior
    • immunosuppression issues
    • MBD issues
  • Survival matching
  • The importance of immunologic compatibility in recipients likely to require repeat transplantation
  • Timing of dialysis recommencement
  • Vaccination recommendations, risks, and benefits

PCH

  • Growth in children post transplantation
  • Maintain adequate perfusion where there is a mismatch between donor and recipient blood pressure
  • Patients with substantial native urine output at transplantation
  • Peri-operative complications specific to small children at transplantation, e.g. abdominal compartment syndrome
  • The effects of immunosuppression in children
  • The increased risk of graft thrombosis among small children, and practises to minimise this risk